Monday, August 20, 2018 -- More than 41,000 people in Europe have been infected with measles this year.
Thursday, August 16, 2018 -- The approval sets the stage for cheaper competition that may lower prices.
Wednesday, August 15, 2018 -- 107 measles cases have been reported in the United States this year.
Friday, August 17, 2018 -- The FDA says this will lower drug costs, but the company has yet to reveal a price.
Wednesday, August 15, 2018 -- The steroid drug is intended to help women who suffer from the hormone-driven condition -- Read more on ScientificAmerican.com
Monday, August 20, 2018 -- In a new study, NCI-led researchers developed a gene expression predictor that can indicate whether melanoma in a specific patient is likely to respond to treatment with immune checkpoint inhibitors, a type of immunotherapy.
Friday, August 17, 2018 -- The U.S. Food and Drug Administration (FDA) has approved Kalydeco (ivacaftor) as the first-ever therapy to treat the underlying cause of cystic fibrosis (CF) in 1-year-old toddlers, Vertex Pharmaceuticals announced. “Parents and physicians now have a medicine to treat the underlying cause of CF in patients as young as one year of age,” Reshma Kewalramani, MD, Vertex’s […] The post FDA Expands Kalydeco’s Approval to 1-year-old Toddlers with Cystic Fibrosis appeared first on Cystic Fibrosis News Today.
Thursday, August 16, 2018 -- A study in mice showed it is possible to transplant stem cells into the lungs and replenish the airways with healthy cells, an approach that could combat cystic fibrosis and alleviate its symptoms. Researchers used stem cells from the airways of cystic fibrosis (CF) patients, which were corrected to produce a normal CFTR gene before being […] The post Stem Cell Transplant Into Airways Might Treat CF, Mouse Study Suggests appeared first on Cystic Fibrosis News Today.
Wednesday, August 15, 2018 -- GlaxoSmithKline has seen positive clinical results from the phase 3 study of its once-monthly injectable HIV treatment, stepping closer to potentially changing lives of patients living with the virus. GSK's global specialist HIV subsidiary, ViiV H...
Saturday, August 18, 2018 -- Having a preference for evening activities, as well as sleeping at different times in the weekdays and weekends, may lead to weight gain in some people.
Friday, August 17, 2018 -- Can weight loss cause a person with type 2 diabetes to go into remission? The Diabetes Remission Clinical Trial found that “substantial weight loss can reverse the processes underlying type 2 diabetes”. The researchers involved say they found that weight loss in patients with type 2 diabetes normalized the fat content in their livers, lowered […]
Saturday, August 18, 2018 -- In a follow-up on the imported measles situation in Brazil, the Ministry of Health reported this week that the 910 cases of measles have been confirmed in Amazonas, 5,630 remain under investigation. In addition, the state of Roraima has confirmed 296 cases of the disease and 101 are still under investigation. All the cases are imported […] The post Brazil’s imported measles situation grows, USNS Comfort headed to Colombia to provide relief appeared first on Outbreak News Today.
Monday, August 20, 2018 -- BACKGROUND: Testing for high-sensitivity cardiac troponin (hs-cTn) may assist triage and clinical decision-making in patients presenting to the emergency department with symptoms of acute coronary syndrome; however, this could result in the misclassification of risk because of analytical variation or laboratory error. We sought to evaluate a new laboratory-based risk-stratification tool that incorporates tests for hs-cTn, glucose level and estimated glomerular filtration rate to identify patients at risk of myocardial infarction or death when presenting to the emergency department. METHODS: We constructed the clinical chemistry score (CCS) (range 0–5 points) and validated it as a predictor of 30-day myocardial infarction (MI) or death using data from 4 cohort studies involving patients who presented to the emergency department with symptoms
Wednesday, August 15, 2018 -- In addition to mutations in the CFTR gene, cystic fibrosis (CF) patients with pancreatitis also have a high prevalence of mutations in genes regulating pancreatic function, according to researchers. Conducted by a research team in Italy, the study, “Trans-heterozygosity for mutations enhances the risk of recurrent/chronic pancreatitis in patients with Cystic Fibrosis,” was published in […] The post Mutations in Genes Regulating Digestion Prevalent in CF Patients with Pancreatitis, Study Finds appeared first on Cystic Fibrosis News Today.
Monday, August 20, 2018 -- Laparoscopic surgery in idiopathic pulmonary fibrosis (IPF) patients with acid reflux is safe and well-tolerated, but does not appear to significantly ease the decline in respiratory function that’s thought to be aggravated by reflux, according to a Phase 2 study. The research, “Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, […] The post Acid-reflux Surgery Appears Safe for IPF But Not Likely to Slow Respiratory Decline, Phase 2 Data Shows appeared first on Pulmonary Fibrosis News.
Friday, August 17, 2018 -- Recent research investigates the importance of breakfast for diabetes. Learn what it's discovered, and how you can get the most out of the most important meal of the day... The post The Importance of Breakfast for Diabetes appeared first on Diabetes Self-Management.
Monday, August 20, 2018 -- U.S. scientists suggest that the antidepressant fluoxetine may represent a new approach to holding back sensory and cognitive decline that occur as a natural part of aging in the brain. Research in mice by Ronen Eavri, Ph.D., and a team at the Massachusetts Institute of Technology’s (MIT) Picower Institute for Learning and Memory, found that normal brain aging is associated with a reduction in the ability of inhibitory interneurons to change and adapt, rather than with a decline in the absolute numbers of these neurons. Their studies in mice showed that this decline in neuronal plasticity in the visual cortex could be held back by treatment using fluoxetine. “Our finding that fluoxetine treatment in aging mice can attenuate the
Monday, August 20, 2018 -- Vertex’s Orkambi (lumacaftor+ivacaftor) cystic fibrosis drug is to be reimbursed in Australia’s publicly funded health system after it was cleared by a cost-effectiveness committee. The decision from Australia’s Pharmaceutical Benefits Advisory Co...
Wednesday, August 15, 2018 -- In May, the Food and Drug Administration posted a drug shortage alert, adding Mylan's EpiPen (epinephrine injection) to the drug shortage list.
Wednesday, August 15, 2018 -- (Natural News) Patients with Type 2 diabetics may have a new, natural means of treating their complicated disease. Sri Lankan researchers tested the leaves of the red sandalwood for anti-diabetic properties. They reported that the leaves of this Ayurvedic medicinal plant possess potent anti-diabetic and antioxidant activity. Nine out of every 10 diabetics have Type... Read More